Department of Medicine/Nephrology, University of Alabama at Birmingham, Birmingham, AL, USA.
Mayo Clin Proc. 2013 Sep;88(9):987-95. doi: 10.1016/j.mayocp.2013.06.005.
The objective of this review was to provide a synthesis of the evidence on the effect of dietary salt and potassium intake on population blood pressure, cardiovascular disease, and mortality. Dietary guidelines and recommendations are outlined, current controversies regarding the evidence are discussed, and recommendations are made on the basis of the evidence. Designed search strategies were used to search various databases for available studies. Randomized trials of the effect of dietary salt intake reduction or increased potassium intake on blood pressure, target organ damage, cardiovascular disease, and mortality were included. Fifty-two publications from January 1, 1990, to January 31, 2013, were identified for inclusion. Consideration was given to variations in the search terms used and the spelling of terms so that studies were not overlooked, and search terms took the following general form: (dietary salt or dietary sodium or [synonyms]) and (dietary potassium or [synonyms]) and (blood pressure or hypertension or vascular disease or heart disease or chronic kidney disease or stroke or mortality or [synonyms]). Evidence from these studies demonstrates that high salt intake not only increases blood pressure but also plays a role in endothelial dysfunction, cardiovascular structure and function, albuminuria and kidney disease progression, and cardiovascular morbidity and mortality in the general population. Conversely, dietary potassium intake attenuates these effects, showing a linkage to reduction in stroke rates and cardiovascular disease risk. Various subpopulations, such as overweight and obese individuals and aging adults, exhibit greater sensitivity to the effects of reduced salt intake and may gain the most benefits. A diet that includes modest salt restriction while increasing potassium intake serves as a strategy to prevent or control hypertension and decrease cardiovascular morbidity and mortality. Thus, the body of evidence supports population-wide sodium intake reduction and recommended increases in dietary potassium intake as outlined by current guidelines as an essential public health effort to prevent kidney disease, stroke, and cardiovascular disease.
本综述的目的是综合有关饮食盐和钾摄入量对人群血压、心血管疾病和死亡率影响的证据。概述了饮食指南和建议,讨论了目前对此证据的争议,并根据证据提出了建议。使用设计的搜索策略在各种数据库中搜索了有关研究。纳入了饮食盐摄入量减少或钾摄入量增加对血压、靶器官损害、心血管疾病和死亡率影响的随机试验。从 1990 年 1 月 1 日至 2013 年 1 月 31 日,确定了 52 篇符合纳入标准的文献。考虑到使用的搜索词和术语拼写的变化,以避免忽略研究,因此搜索词采用以下一般形式:(饮食盐或饮食钠或[同义词])和(饮食钾或[同义词])和(血压或高血压或血管疾病或心脏病或慢性肾病或中风或死亡率或[同义词])。这些研究的证据表明,高盐摄入不仅会升高血压,还会导致内皮功能障碍、心血管结构和功能、蛋白尿和肾脏疾病进展以及一般人群的心血管发病率和死亡率。相反,饮食钾摄入可减弱这些影响,表明与中风发生率和心血管疾病风险降低有关。各种亚人群,如超重和肥胖个体以及老年人,对低盐摄入的影响更为敏感,可能会从中获得最大益处。包括适度低盐摄入和增加钾摄入的饮食策略可作为预防或控制高血压以及降低心血管发病率和死亡率的策略。因此,现有证据支持在人群中减少钠摄入和增加钾摄入,正如当前指南所概述的那样,这是预防肾脏疾病、中风和心血管疾病的一项重要公共卫生措施。